TY  - GEN
AU  - van den Eertwegh,Alfonsus J M
AU  - Karakiewicz,Pierre
AU  - Bavbek,Sevil
AU  - Rha,Sun Young
AU  - Bracarda,Sergio
AU  - Bahl,Amit
AU  - Ou,Yen-chuan
AU  - Kim,Dennis
AU  - Panneerselvam,Ashok
AU  - Anak,Oezlem
AU  - Grünwald,Viktor
TI  - Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program
SN  - 1527-9995
PY  - 2013///0322
KW  - Aged
KW  - Anemia
KW  - chemically induced
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Disease Progression
KW  - Dyspnea
KW  - Everolimus
KW  - Fatigue
KW  - Female
KW  - Humans
KW  - Hyperglycemia
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Pneumonia
KW  - Sirolimus
KW  - Stomatitis
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.urology.2012.09.019
ER  -